{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:39:28Z","timestamp":1790703568851,"version":"4.1.0"},"reference-count":189,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01685","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T04:23:05Z","timestamp":1597378985000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":75,"title":["HLA-G Neo-Expression on Tumors"],"prefix":"10.3389","volume":"11","author":[{"given":"Maria","family":"Loustau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaelle","family":"Dr\u00e9an","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Langlade-Demoyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Caumartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"B1","first-page":"610","article-title":"Telomerase activity in human endometrium","volume":"57","author":"Kyo","year":"1997","journal-title":"Cancer Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.7605428","article-title":"Specific association of human telomerase activity with immortal cells and cancer","volume":"266","author":"Kim","year":"1994","journal-title":"Science."},{"key":"B3","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/25141","article-title":"Control of apoptosis and mitotic spindle checkpoint by survivin","volume":"396","author":"Li","year":"1998","journal-title":"Nature."},{"key":"B4","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/s0029-7844(01)01131-0","article-title":"Localization of telomerase hTERT protein and survivin in placenta: relation to placental development and hydatidiform mole","volume":"97","author":"Lehner","year":"2001","journal-title":"Obstet Gynecol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/s0143-4004(97)90007-2","article-title":"Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast","volume":"18","author":"Shore","year":"1997","journal-title":"Placenta."},{"key":"B6","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1158\/0008-5472.CAN-08-0925","article-title":"Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cells","volume":"68","author":"Shojaei","year":"2008","journal-title":"Cancer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.4049\/jimmunol.154.8.3771","article-title":"Human placental HLA-G expression is restricted to differentiated cytotrophoblasts","volume":"154","author":"McMaster","year":"1995","journal-title":"J Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-2249.2004.02441.x","article-title":"Phenotypic characterization of regulatory T cells in the human decidua","volume":"136","author":"Heikkinen","year":"2004","journal-title":"Clin Exp Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e2078","DOI":"10.1371\/journal.pone.0002078","article-title":"Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype","volume":"3","author":"Gustafsson","year":"2008","journal-title":"PLoS ONE."},{"key":"B11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/molehr\/gal073","article-title":"An in vitro model of human placental trophoblast deportation\/shedding","volume":"12","author":"Abumaree","year":"2006","journal-title":"Mol Hum Reprod."},{"key":"B12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.32607\/20758251-2015-7-2-17-28","article-title":"Cancer invasion: patterns and mechanisms","volume":"7","author":"Krakhmal","year":"2015","journal-title":"Acta Nat."},{"key":"B13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.it.2007.11.005","article-title":"HLA-G: from biology to clinical benefits","volume":"29","author":"Carosella","year":"2008","journal-title":"Trends Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1073\/pnas.95.8.4510","article-title":"HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance","volume":"95","author":"Paul","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00251-003-0547-z","article-title":"HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels","volume":"55","author":"Hviid","year":"2003","journal-title":"Immunogenetics."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1007\/s00018-012-1069-3","article-title":"Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors","volume":"69","author":"HoWangYin","year":"2012","journal-title":"Cell Mol Life Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.4049\/jimmunol.1601296","article-title":"Cutting edge: class ii-like structural features and strong receptor binding of the nonclassical HLA-G2 isoform homodimer","volume":"198","author":"Kuroki","year":"2017","journal-title":"J Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbrc.2017.03.149","article-title":"A soluble recombinant form of human leucocyte antigen-G 6 (srHLA-G6)","volume":"487","author":"Pela","year":"2017","journal-title":"Biochem Biophys Res Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.humimm.2006.09.003","article-title":"Structural studies on HLA-G: implications for ligand and receptor binding","volume":"68","author":"Clements","year":"2007","journal-title":"Hum Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fimmu.2012.00258","article-title":"KIR2DL4 (CD158d): an activation receptor for HLA-G.","volume":"3","author":"Rajagopalan","year":"2012","journal-title":"Front Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"10460","DOI":"10.1074\/jbc.M114.612291","article-title":"The structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4","volume":"290","author":"Moradi","year":"2015","journal-title":"J Biol Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.0001-2815.2004.00290.x","article-title":"The LILR family: modulators of innate and adaptive immune pathways in health and disease","volume":"64","author":"Brown","year":"2004","journal-title":"Tissue Antigens."},{"key":"B23","doi-asserted-by":"publisher","first-page":"16412","DOI":"10.1073\/pnas.0605228103","article-title":"Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2\/LIR2\/ILT4\/CD85d)","volume":"103","author":"Shiroishi","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/intimm\/11.6.889","article-title":"HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein","volume":"11","author":"Mallet","year":"1999","journal-title":"Int Immunol."},{"key":"B25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1084\/jem.186.2.289","article-title":"Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts","volume":"186","author":"Crisa","year":"1997","journal-title":"J Exp Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.humimm.2003.08.346","article-title":"Expression of HLA-G in human cornea, an immune-privileged tissue","volume":"64","author":"Le Discorde","year":"2003","journal-title":"Hum Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.2337\/db05-0731","article-title":"The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G.","volume":"55","author":"Cirulli","year":"2006","journal-title":"Diabetes."},{"key":"B28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.tp.0000267918.07906.08","article-title":"Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.","volume":"84","author":"Nasef","year":"2007","journal-title":"Transplantation."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1002\/stem.1494","article-title":"Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy","volume":"31","author":"Naji","year":"2013","journal-title":"Stem Cells."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1182\/blood-2004-03-0809","article-title":"Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis","volume":"104","author":"Menier","year":"2004","journal-title":"Blood."},{"key":"B31","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/sj.leu.2405050","article-title":"HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera","volume":"22","author":"Menier","year":"2008","journal-title":"Leukemia."},{"key":"B32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3324\/haematol.2014.113803","article-title":"HLA-G expression levels influence the tolerogenic activity of human DC-10","volume":"100","author":"Amodio","year":"2015","journal-title":"Haematologica."},{"key":"B33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1189\/jlb.1008649","article-title":"T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible","volume":"86","author":"Huang","year":"2009","journal-title":"J Leukoc Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1096\/fj.14-251074","article-title":"Human CD4+ HLA-G+ regulatory T cells are potent suppressors of graft-versus-host disease in vivo","volume":"28","author":"Pankratz","year":"2014","journal-title":"FASEB J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/molehr\/gah185","article-title":"The soluble pool of HLA-G produced by human trophoblasts does not include detectable levels of the intron 4-containing HLA-G5 and HLA-G6 isoforms","volume":"11","author":"Blaschitz","year":"2005","journal-title":"Mol Hum Reprod."},{"key":"B36","doi-asserted-by":"publisher","first-page":"s361","DOI":"10.2450\/2012.0144-12","article-title":"The plasma levels of soluble HLA-G molecules correlate directly with CD34+ cell concentration and HLA-G 14bp insertion\/insertion polymorphism in cord blood donors","volume":"12","author":"Capittini","year":"2014","journal-title":"Blood Transfus."},{"key":"B37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1399-0039.2006.00540.x","article-title":"HLA-G levels in serum and plasma","volume":"67","author":"Rudstein-Svetlicky","year":"2006","journal-title":"Tissue Antigens."},{"key":"B38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0165-5728(03)00266-2","article-title":"Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings","volume":"142","author":"Fainardi","year":"2003","journal-title":"J Neuroimmunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1177\/1352458507085137","article-title":"CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis","volume":"14","author":"Fainardi","year":"2008","journal-title":"Mult Scler."},{"key":"B40","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/molehr\/gar052","article-title":"Human leukocyte antigen-G in the male reproductive system and in seminal plasma","volume":"17","author":"Larsen","year":"2011","journal-title":"Mol Hum Reprod."},{"key":"B41","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/humrep\/deh572","article-title":"Embryonic soluble HLA-G as a marker of developmental potential in embryos","volume":"20","author":"Noci","year":"2005","journal-title":"Hum Reprod."},{"key":"B42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.5115\/acb.2011.44.4.331","article-title":"Increase in concentration of soluble HLA-G in high-quality embryos after intracytoplasmic sperm injection","volume":"44","author":"Heidari","year":"2011","journal-title":"Anat Cell Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/1521-4141(200202)32:2<311::AID-IMMU311>3.0.CO;2-8","article-title":"HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy","volume":"32","author":"Fuzzi","year":"2002","journal-title":"Eur J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"10139","DOI":"10.1158\/0008-5472.CAN-05-0097","article-title":"HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?","volume":"65","author":"Rouas-Freiss","year":"2005","journal-title":"Cancer Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"359748","DOI":"10.1155\/2014\/359748","article-title":"The dual role of HLA-G in cancer","volume":"2014","author":"Rouas-Freiss","year":"2014","journal-title":"J Immunol Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0929-6646(10)60050-2","article-title":"HLA-G and immune evasion in cancer cells","volume":"109","author":"Sheu","year":"2010","journal-title":"J Formos Med Assoc."},{"key":"B47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1465-9921-14-4","article-title":"Human leukocyte antigen-G expression in differentiated human airway epithelial cells: lack of modulation by Th2-associated cytokines","volume":"14","author":"White","year":"2013","journal-title":"Respir Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3389\/fimmu.2014.00592","article-title":"HLA-G molecules in autoimmune diseases and infections","volume":"5","author":"Rizzo","year":"2014","journal-title":"Front Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ana.21705","article-title":"Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis","volume":"66","author":"Huang","year":"2009","journal-title":"Ann Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"15226","DOI":"10.1128\/JVI.79.24.15226-15237.2005","article-title":"Modulation of HLA-G expression in human neural cells after neurotropic viral infections","volume":"79","author":"Lafon","year":"2005","journal-title":"J Virol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"298569","DOI":"10.1155\/2014\/298569","article-title":"Immunomodulatory properties of HLA-G in infectious diseases","volume":"2014","author":"Amiot","year":"2014","journal-title":"J Immunol Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jhep.2013.09.006","article-title":"Expression of HLA-G by mast cells is associated with hepatitis C virus-induced liver fibrosis","volume":"60","author":"Amiot","year":"2014","journal-title":"J Hepatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/eji.200324266","article-title":"Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients","volume":"34","author":"Le Rond","year":"2004","journal-title":"Eur J Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/ajt.12977","article-title":"Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study","volume":"15","author":"Brugiere","year":"2015","journal-title":"Am J Transplant."},{"key":"B55","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/187153011794982059","article-title":"HLA-G expression in cancers: potential role in diagnosis, prognosis and therapy","volume":"11","author":"Yan","year":"2011","journal-title":"Endocr Metab Immune Disord Drug Targets."},{"key":"B56","doi-asserted-by":"publisher","first-page":"7021","DOI":"10.1182\/blood-2010-07-294389","article-title":"Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1\/Th17","volume":"117","author":"Agaugue","year":"2011","journal-title":"Blood."},{"key":"B57","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/ijc.26375","article-title":"HLA-G expression is associated with metastasis and poor survival in the Balb\/c nu\/nu murine tumor model with ovarian cancer","volume":"131","author":"Lin","year":"2012","journal-title":"Int J Cancer."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1002\/ijc.28845","article-title":"In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance","volume":"135","author":"Loumagne","year":"2014","journal-title":"Int J Cancer."},{"key":"B59","first-page":"1954","article-title":"Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies","volume":"59","author":"Paul","year":"1999","journal-title":"Cancer Res."},{"key":"B60","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1073\/pnas.94.21.11520","article-title":"Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis","volume":"94","author":"Rouas-Freiss","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B61","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1073\/pnas.94.10.5249","article-title":"The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?","volume":"94","author":"Rouas-Freiss","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B62","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/intimm\/11.8.1351","article-title":"HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes","volume":"11","author":"Le Gal","year":"1999","journal-title":"Int Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1073\/pnas.201407398","article-title":"Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism","volume":"98","author":"Lila","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/sj.emboj.7601570","article-title":"Trogocytosis-based generation of suppressive NK cells","volume":"26","author":"Caumartin","year":"2007","journal-title":"EMBO J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.4049\/jimmunol.176.3.1331","article-title":"Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes","volume":"176","author":"Bahri","year":"2006","journal-title":"J Immunol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.4049\/jimmunol.1300438","article-title":"Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses","volume":"192","author":"Naji","year":"2014","journal-title":"J Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"17957","DOI":"10.1073\/pnas.1221535110","article-title":"Exocytosis acts as a modulator of the ILT4-mediated inhibition of neutrophil functions","volume":"110","author":"Baudhuin","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B68","doi-asserted-by":"publisher","first-page":"e11763","DOI":"10.1371\/journal.pone.0011763","article-title":"A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis","volume":"5","author":"Morandi","year":"2010","journal-title":"PLoS ONE."},{"key":"B69","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.1182\/blood-2011-05-352393","article-title":"Soluble HLA-G dampens CD94\/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells","volume":"118","author":"Morandi","year":"2011","journal-title":"Blood."},{"key":"B70","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/eji.200736918","article-title":"Soluble HLA-G molecules impair natural killer\/dendritic cell crosstalk via inhibition of dendritic cells","volume":"38","author":"Gros","year":"2008","journal-title":"Eur J Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1182\/blood-2006-05-024547","article-title":"Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells","volume":"109","author":"LeMaoult","year":"2007","journal-title":"Blood."},{"key":"B72","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.1182\/blood-2011-07-370742","article-title":"The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells","volume":"118","author":"Carosella","year":"2011","journal-title":"Blood."},{"key":"B73","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1046\/j.1365-2141.2002.03814.x","article-title":"Major histocompatibility complex abnormalities in non-Hodgkin lymphomas","volume":"119","author":"Drenou","year":"2002","journal-title":"Br J Haematol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1182\/blood-2004-08-3335","article-title":"HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia","volume":"105","author":"Nuckel","year":"2005","journal-title":"Blood."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.humimm.2003.08.345","article-title":"Soluble HLA-G molecules are increased in lymphoproliferative disorders","volume":"64","author":"Sebti","year":"2003","journal-title":"Hum Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1593\/neo.05703","article-title":"Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages","volume":"8","author":"Gros","year":"2006","journal-title":"Neoplasia."},{"key":"B77","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00005-015-0372-8","article-title":"HLA-G and MHC class II protein expression in diffuse large B-Cell lymphoma","volume":"64","author":"Jesionek-Kupnicka","year":"2016","journal-title":"Arch Immunol Ther Exp (Warsz)."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.4081\/ejh.2016.2606","article-title":"HLA-G expression and role in advanced-stage classical Hodgkin lymphoma","volume":"60","author":"Caocci","year":"2016","journal-title":"Eur J Histochem."},{"key":"B79","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1399-0039.2008.01005.x","article-title":"HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma","volume":"71","author":"Diepstra","year":"2008","journal-title":"Tissue Antigens."},{"key":"B80","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/s1044-579x(03)00024-5","article-title":"HLA-G and IL-10 expression in human cancer\u2013different stories with the same message","volume":"13","author":"Urosevic","year":"2003","journal-title":"Semin Cancer Biol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1182\/blood-2003-10-3372","article-title":"Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2","volume":"103","author":"Urosevic","year":"2004","journal-title":"Blood."},{"key":"B82","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of cancer immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annu Rev Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1096\/fj.09-135194","article-title":"ILT2\/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse","volume":"24","author":"Favier","year":"2010","journal-title":"FASEB J."},{"key":"B84","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ijc.10460","article-title":"MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal","volume":"100","author":"Menier","year":"2002","journal-title":"Int J Cancer."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/eji.200425741","article-title":"Tolerization of dendritic cells by HLA-G.","volume":"35","author":"Ristich","year":"2005","journal-title":"Eur J Immunol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1158\/1541-7786.MCR-14-0150","article-title":"Hypoxia promotes dissemination and colonization in new bone marrow niches in Waldenstrom macroglobulinemia","volume":"13","author":"Muz","year":"2015","journal-title":"Mol Cancer Res."},{"key":"B87","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/intimm\/11.5.803","article-title":"IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes","volume":"11","author":"Moreau","year":"1999","journal-title":"Int Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"4326495","DOI":"10.1155\/2016\/4326495","article-title":"Recent advances in our understanding of HLA-G biology: lessons from a wide spectrum of human diseases","volume":"2016","author":"Morandi","year":"2016","journal-title":"J Immunol Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1182\/blood.v99.2.609","article-title":"HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas","volume":"99","author":"Urosevic","year":"2002","journal-title":"Blood."},{"key":"B90","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ijc.11456","article-title":"Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype","volume":"108","author":"Ibrahim","year":"2004","journal-title":"Int J Cancer."},{"key":"B91","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0002-9440(10)61756-7","article-title":"Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production","volume":"159","author":"Urosevic","year":"2001","journal-title":"Am J Pathol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3892\/ijmm.2.3.349","article-title":"Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells","volume":"2","author":"Fukushima","year":"1998","journal-title":"Int J Mol Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/path.1039","article-title":"Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer","volume":"196","author":"Lefebvre","year":"2002","journal-title":"J Pathol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0002-9440(10)61675-6","article-title":"HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?","volume":"159","author":"Aractingi","year":"2001","journal-title":"Am J Pathol."},{"key":"B95","first-page":"4460","article-title":"HLA-G is a potential tumor marker in malignant ascites","volume":"9","author":"Singer","year":"2003","journal-title":"Clin Cancer Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/modpathol.3800751","article-title":"Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer","volume":"20","author":"Ye","year":"2007","journal-title":"Mod Pathol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1245\/s10434-007-9464-y","article-title":"Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma","volume":"14","author":"Yie","year":"2007","journal-title":"Ann Surg Oncol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1179\/102453309X385197","article-title":"HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?","volume":"14","author":"Erikci","year":"2009","journal-title":"Hematology."},{"key":"B99","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1582-4934.2008.00175.x","article-title":"Unfavourable clinical implications for HLA-G expression in acute myeloid leukaemia","volume":"12","author":"Yan","year":"2008","journal-title":"J Cell Mol Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.humimm.2003.08.344","article-title":"Exosomes bearing HLA-G are released by melanoma cells","volume":"64","author":"Riteau","year":"2003","journal-title":"Hum Immunol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: an immune checkpoint molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bcmd.2005.07.001","article-title":"Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis","volume":"35","author":"Abusamra","year":"2005","journal-title":"Blood Cells Mol Dis."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1186\/s12885-015-2025-z","article-title":"Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation","volume":"15","author":"Grange","year":"2015","journal-title":"BMC Cancer."},{"key":"B104","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.humimm.2016.01.002","article-title":"The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients","volume":"77","author":"Konig","year":"2016","journal-title":"Hum Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.3390\/cancers11081106","article-title":"Vesicular-bound HLA-G as a predictive marker for disease progression in epithelial ovarian cancer","volume":"11","author":"Schwich","year":"2019","journal-title":"Cancers (Basel)."},{"key":"B106","first-page":"6838","article-title":"Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma","volume":"61","author":"Ibrahim","year":"2001","journal-title":"Cancer Res."},{"key":"B107","first-page":"4107","article-title":"Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma","volume":"63","author":"Bukur","year":"2003","journal-title":"Cancer Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/s1044-579x(03)00026-9","article-title":"The role of HLA-G for protection of human renal cell-carcinoma cells from immune-mediated lysis: implications for immunotherapies","volume":"13","author":"Bukur","year":"2003","journal-title":"Semin Cancer Biol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1399-0039.2008.01090.x","article-title":"Expression and regulation of non-classical HLA-G in renal cell carcinoma","volume":"72","author":"Dunker","year":"2008","journal-title":"Tissue Antigens."},{"key":"B110","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.semcancer.2007.07.001","article-title":"Structure, expression and function of HLA-G in renal cell carcinoma","volume":"17","author":"Seliger","year":"2007","journal-title":"Semin Cancer Biol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/1878-0261.12119","article-title":"Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients","volume":"11","author":"Tronik-Le Roux","year":"2017","journal-title":"Mol Oncol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s00262-020-02530-x","article-title":"Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets","volume":"69","author":"Tronik-Le Roux","year":"2020","journal-title":"Cancer Immunol Immunother."},{"key":"B113","doi-asserted-by":"publisher","first-page":"e1342023","DOI":"10.1080\/2162402X.2017.1342023","article-title":"Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: focus on HLA-G\/ILT2\/ILT4","volume":"6","author":"Rouas-Freiss","year":"2017","journal-title":"Oncoimmunology."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1158\/2326-6066.CIR-18-0764","article-title":"CD8(+)PD-1(-)ILT2(+) T cells are an intratumoral cytotoxic population selectively inhibited by the immune-checkpoint HLA-G.","volume":"7","author":"Dumont","year":"2019","journal-title":"Cancer Immunol Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.humimm.2016.03.001","article-title":"HLA-G and classical HLA class I expression in primary colorectal cancer and associated liver metastases","volume":"77","author":"Swets","year":"2016","journal-title":"Hum Immunol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1073\/pnas.95.9.5199","article-title":"HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A.","volume":"95","author":"Lee","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1309\/JNCW1QLDFB6AM9WE","article-title":"Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma","volume":"128","author":"Yie","year":"2007","journal-title":"Am J Clin Pathol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.imlet.2014.04.007","article-title":"Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis","volume":"161","author":"Zheng","year":"2014","journal-title":"Immunol Lett."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/ijc.25807","article-title":"Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma","volume":"129","author":"Lin","year":"2011","journal-title":"Int J Cancer."},{"key":"B120","doi-asserted-by":"publisher","first-page":"7681","DOI":"10.7314\/apjcp.2013.14.12.7681","article-title":"Immunoregulatory function of HLA-G in gastric cancer","volume":"14","author":"Tuncel","year":"2013","journal-title":"Asian Pac J Cancer Prev."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/j.1349-7006.2011.01951.x","article-title":"Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells","volume":"102","author":"Du","year":"2011","journal-title":"Cancer Sci."},{"key":"B122","first-page":"2036","article-title":"HLA-G impairs host immune response and predicts poor prognosis in pancreatic cancer","volume":"7","author":"Zhou","year":"2015","journal-title":"Am J Transl Res."},{"key":"B123","first-page":"28","article-title":"Prognostic value of HLA-G in malignant liver and pancreas lesions","volume":"15","author":"Khodabandeh Shahraki","year":"2018","journal-title":"Iran J Immunol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"360","DOI":"10.2174\/1566524015666150401102218","article-title":"High expression of human leukocyte antigen-g is associated with a poor prognosis in patients with PDAC.","volume":"15","author":"Xu","year":"2015","journal-title":"Curr Mol Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1158\/1078-0432.CCR-09-0463","article-title":"Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection","volume":"15","author":"Cai","year":"2009","journal-title":"Clin Cancer Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/s1499-3872(11)60025-8","article-title":"Expression of HLA-G in patients with hepatocellular carcinoma","volume":"10","author":"Wang","year":"2011","journal-title":"Hepatobiliary Pancreat Dis Int."},{"key":"B127","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1111\/j.1582-4934.2009.00917.x","article-title":"Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma","volume":"14","author":"Lin","year":"2010","journal-title":"J Cell Mol Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.humimm.2003.08.357","article-title":"Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms","volume":"64","author":"Chang","year":"2003","journal-title":"Hum Immunol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1073\/pnas.94.15.8104","article-title":"Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth","volume":"94","author":"Maxwell","year":"1997","journal-title":"Proc Natl Acad Sci USA."},{"key":"B130","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1089\/thy.2013.0246","article-title":"HLA-G is differentially expressed in thyroid tissues","volume":"24","author":"de Figueiredo Feitosa","year":"2014","journal-title":"Thyroid."},{"key":"B131","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.humimm.2012.12.012","article-title":"Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer","volume":"74","author":"Nunes","year":"2013","journal-title":"Hum Immunol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.clindermatol.2008.09.001","article-title":"Melanoma epidemiology and trends","volume":"27","author":"Garbe","year":"2009","journal-title":"Clin Dermatol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"v61","DOI":"10.1093\/annonc\/mdg754","article-title":"EUROCARE-3: survival of cancer patients diagnosed 1990-94\u2013results and commentary","volume":"14","author":"Sant","year":"2003","journal-title":"Ann Oncol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0002-9440(10)63844-8","article-title":"Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma","volume":"162","author":"Ibrahim","year":"2003","journal-title":"Am J Pathol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/1097-0142(20010715)92:2<369::aid-cncr1332>3.0.co;2-u","article-title":"Soluble human leukocyte antigen\u2013G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy","volume":"92","author":"Ugurel","year":"2001","journal-title":"Cancer."},{"key":"B136","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(00)02486-7","article-title":"Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma","volume":"356","author":"Wagner","year":"2000","journal-title":"Lancet."},{"key":"B137","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0165-0378(99)00037-6","article-title":"HLA-G expression in human melanoma cells: protection from NK cytolysis","volume":"43","author":"Adrian Cabestre","year":"1999","journal-title":"J Reprod Immunol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1056\/NEJM200101113440207","article-title":"Brain tumors","volume":"344","author":"DeAngelis","year":"2001","journal-title":"N Engl J Med."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2015.02.013","article-title":"Tumor border sharpness correlates with HLA-G expression in low-grade gliomas","volume":"282","author":"Wang","year":"2015","journal-title":"J Neuroimmunol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ajpath.2012.10.021","article-title":"Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-gamma treatments: results from a multicentric study","volume":"182","author":"Wastowski","year":"2013","journal-title":"Am J Pathol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.4049\/jimmunol.168.9.4772","article-title":"A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape","volume":"168","author":"Wiendl","year":"2002","journal-title":"J Immunol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"43","DOI":"10.7314\/apjcp.2016.17.s3.43","article-title":"Incidence and mortality and epidemiology of breast cancer in the world","volume":"17","author":"Ghoncheh","year":"2016","journal-title":"Asian Pac J Cancer Prev."},{"key":"B143","doi-asserted-by":"publisher","first-page":"103671","DOI":"10.18632\/oncotarget.22110","article-title":"Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer","volume":"8","author":"Ogiya","year":"2017","journal-title":"Oncotarget."},{"key":"B144","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1093\/annonc\/mdy399","article-title":"Immunological differences between primary and metastatic breast cancer","volume":"29","author":"Szekely","year":"2018","journal-title":"Ann Oncol."},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1200\/PO.18.00335","article-title":"Data from genomic and immune profiling of a patient with triple-negative breast cancer that progressed during neoadjuvant chemotherapy plus PD-L1 blockade","author":"Casadevall","year":"2019","journal-title":"JCO Precis Oncol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1245\/s10434-009-0891-9","article-title":"HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro","volume":"17","author":"He","year":"2010","journal-title":"Ann Surg Oncol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.humimm.2010.06.009","article-title":"Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer","volume":"71","author":"Chen","year":"2010","journal-title":"Hum Immunol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.4049\/jimmunol.1002629","article-title":"HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients","volume":"185","author":"de Kruijf","year":"2010","journal-title":"J Immunol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"250435","DOI":"10.1155\/2013\/250435","article-title":"Expression of the classical and nonclassical HLA molecules in breast cancer","volume":"2013","author":"da Silva","year":"2013","journal-title":"Int J Breast Cancer."},{"key":"B150","doi-asserted-by":"publisher","first-page":"e1169356","DOI":"10.1080\/2162402X.2016.1169356","article-title":"Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy","volume":"5","author":"Ishibashi","year":"2016","journal-title":"Oncoimmunology."},{"key":"B151","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jri.2007.12.001","article-title":"Production and characterization of a novel monoclonal antibody against progesterone-induced blocking factor (PIBF)","volume":"78","author":"Ivanova-Todorova","year":"2008","journal-title":"J Reprod Immunol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/humrep\/dei305","article-title":"Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro","volume":"21","author":"Yie","year":"2006","journal-title":"Hum Reprod."},{"key":"B153","first-page":"62","article-title":"[Development of an HPV vaccine\u2013remaining issues and perspective]","volume":"67","author":"Kondo","year":"2009","journal-title":"Nihon Rinsho."},{"key":"B154","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1590\/1516-3180.2013.7170009","article-title":"Greater expression of the human leukocyte antigen-G (HLA-G) and interleukin-17 (IL-17) in cervical intraepithelial neoplasia: analytical cross-sectional study","volume":"133","author":"Miranda","year":"2015","journal-title":"S\u00e3o Paulo Med J."},{"key":"B155","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1182\/blood-2008-09-177360","article-title":"Endogenous IL-17 contributes to reduced tumor growth and metastasis","volume":"114","author":"Kryczek","year":"2009","journal-title":"Blood."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1182\/blood-2009-03-208249","article-title":"Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments","volume":"114","author":"Kryczek","year":"2009","journal-title":"Blood."},{"key":"B157","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.humimm.2012.07.041","article-title":"Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression","volume":"73","author":"Li","year":"2012","journal-title":"Hum Immunol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1369\/jhc.2009.954131","article-title":"Low expression of human histocompatibility soluble leukocyte antigen-G (HLA-G5) in invasive cervical cancer with and without metastasis, associated with papilloma virus (HPV)","volume":"58","author":"Guimaraes","year":"2010","journal-title":"J Histochem Cytochem."},{"key":"B159","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000334089","article-title":"Altered HLA class I and HLA-G expression is associated with IL-10 expression in patients with cervical cancer","volume":"79","author":"Rodriguez","year":"2012","journal-title":"Pathobiology."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1177\/1933719109342131","article-title":"Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer","volume":"16","author":"Jung","year":"2009","journal-title":"Reprod Sci."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.humimm.2009.07.021","article-title":"Human leukocyte antigen-G is expressed in advanced-stage ovarian carcinoma of high-grade histology","volume":"70","author":"Menier","year":"2009","journal-title":"Hum Immunol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ygyno.2006.01.045","article-title":"Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma","volume":"103","author":"Barrier","year":"2006","journal-title":"Gynecol Oncol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/humrep\/dei408","article-title":"HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium","volume":"21","author":"Barrier","year":"2006","journal-title":"Hum Reprod."},{"key":"B164","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.lungcan.2007.06.011","article-title":"Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer","volume":"58","author":"Yie","year":"2007","journal-title":"Lung Cancer."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.humimm.2003.08.354","article-title":"Detection of HLA-G5 secreting cells","volume":"64","author":"Rebmann","year":"2003","journal-title":"Hum Immunol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/jcmm.12400","article-title":"Significance of tumour cell HLA-G5\/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients","volume":"19","author":"Yan","year":"2015","journal-title":"J Cell Mol Med."},{"key":"B167","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.humimm.2010.02.015","article-title":"Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients","volume":"71","author":"Schutt","year":"2010","journal-title":"Hum Immunol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1093\/annonc\/mdm356","article-title":"HLA-G expression in human ovarian carcinoma counteracts NK cell function","volume":"18","author":"Lin","year":"2007","journal-title":"Ann Oncol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.4049\/jimmunol.1402408","article-title":"Acquisition of activation receptor ligand by trogocytosis renders NK cells hyporesponsive","volume":"194","author":"Miner","year":"2015","journal-title":"J Immunol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/s0198-8859(00)00154-3","article-title":"HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression","volume":"61","author":"Paul","year":"2000","journal-title":"Hum Immunol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/s0198-8859(02)00821-2","article-title":"Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules","volume":"64","author":"Menier","year":"2003","journal-title":"Hum Immunol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.humimm.2005.05.003","article-title":"Report of the wet workshop for quantification of soluble HLA-G in Essen, 2004","volume":"66","author":"Rebmann","year":"2005","journal-title":"Hum Immunol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"5947","DOI":"10.3390\/ijms20235947","article-title":"Evaluation of the reactivity and receptor competition of HLA-G isoforms toward available antibodies: implications of structural characteristics of HLA-G isoforms","volume":"20","author":"Furukawa","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B174","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1399-0039.1997.tb02852.x","article-title":"Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody","volume":"50","author":"Loke","year":"1997","journal-title":"Tissue Antigens."},{"key":"B175","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1073\/pnas.0409676102","article-title":"Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface","volume":"102","author":"Clements","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B176","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1746-1596-9-85","article-title":"Inhibitory receptor immunoglobulin-like transcript 4 was highly expressed in primary ductal and lobular breast cancer and significantly correlated with IL-10","volume":"9","author":"Liu","year":"2014","journal-title":"Diagn Pathol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1378\/chest.07-1100","article-title":"Expression of Ig-like transcript 4 inhibitory receptor in human non-small cell lung cancer","volume":"134","author":"Sun","year":"2008","journal-title":"Chest."},{"key":"B178","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/15384101.2015.1121324","article-title":"Inhibitory leukocyte immunoglobulin-like receptors: immune checkpoint proteins and tumor sustaining factors","volume":"15","author":"Kang","year":"2016","journal-title":"Cell Cycle."},{"key":"B179","doi-asserted-by":"publisher","first-page":"21004","DOI":"10.18632\/oncotarget.4217","article-title":"ANGPTL2\/LILRB2 signaling promotes the propagation of lung cancer cells","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget."},{"key":"B180","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature11095","article-title":"Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development","volume":"485","author":"Zheng","year":"2012","journal-title":"Nature."},{"key":"B181","doi-asserted-by":"publisher","first-page":"13822","DOI":"10.18632\/oncotarget.2635","article-title":"An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis","volume":"6","author":"Carbone","year":"2015","journal-title":"Oncotarget."},{"key":"B182","doi-asserted-by":"publisher","first-page":"13550","DOI":"10.18632\/oncotarget.3624","article-title":"Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget."},{"key":"B183","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/ijc.20499","article-title":"Coordinated downregulation of the antigen presentation machinery and HLA class I\/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer","volume":"113","author":"Romero","year":"2005","journal-title":"Int J Cancer."},{"key":"B184","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/ijc.28338","article-title":"Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma","volume":"134","author":"del Campo","year":"2014","journal-title":"Int J Cancer."},{"key":"B185","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1172\/JCI498","article-title":"beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma","volume":"101","author":"Hicklin","year":"1998","journal-title":"J Clin Invest."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/eji.200737515","article-title":"Immune modulation of HLA-G dimer in maternal-fetal interface","volume":"37","author":"Kuroki","year":"2007","journal-title":"Eur J Immunol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s0143-4004(98)90000-5","article-title":"HLA-G1 protein expression is not essential for fetal survival","volume":"19","author":"Ober","year":"1998","journal-title":"Placenta."},{"key":"B188","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1096\/fj.04-2078rev","article-title":"HLA-G and immune tolerance in pregnancy","volume":"19","author":"Hunt","year":"2005","journal-title":"FASEB J."},{"key":"B189","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/ijc.21151","article-title":"Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis","volume":"117","author":"Rouas-Freiss","year":"2005","journal-title":"Int J Cancer."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01685\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T19:08:09Z","timestamp":1696532889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01685\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":189,"alternative-id":["10.3389\/fimmu.2020.01685"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01685","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"article-number":"1685"}}